Vertex Pharmaceuticals

AbCellera Partners with Vertex to Develop Multispecific T-Cell Engagers

VANCOUVER, British Columbia, July 29, 2026 AbCellera Biologics Inc. announced a strategic collaboration with Vertex Pharmaceuticals to research, develop,...

By cGxPwire Editor
July 30, 2026

Pharma

Vertex Secures FDA Approval to Expand CASGEVY Use in Young Children

BOSTON, July 1, 2026 Vertex Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved the expanded...

By cGxPwire Editor
July 2, 2026

.Clinical

Vertex Reports Successful Phase 3 CASGEVY Outcomes in Pediatrics

BOSTON, June 11, 2026 Vertex Pharmaceuticals announced new Phase 3 clinical data demonstrating the potential of CASGEVY® (exagamglogene autotemcel)...